129 related articles for article (PubMed ID: 12445560)
1. Enhanced cellular accumulation of a P-glycoprotein substrate, rhodamine-123, by Caco-2 cells using low molecular weight methoxypolyethylene glycol-block-polycaprolactone diblock copolymers.
Zastre J; Jackson J; Bajwa M; Liggins R; Iqbal F; Burt H
Eur J Pharm Biopharm; 2002 Nov; 54(3):299-309. PubMed ID: 12445560
[TBL] [Abstract][Full Text] [Related]
2. Methoxypolyethylene glycol-block-polycaprolactone diblock copolymers reduce P-glycoprotein efflux in the absence of a membrane fluidization effect while stimulating P-glycoprotein ATPase activity.
Zastre J; Jackson JK; Wong W; Burt HM
J Pharm Sci; 2007 Apr; 96(4):864-75. PubMed ID: 17094135
[TBL] [Abstract][Full Text] [Related]
3. Evidence for modulation of P-glycoprotein-mediated efflux by methoxypolyethylene glycol-block-Polycaprolactone amphiphilic diblock copolymers.
Zastre J; Jackson J; Burt H
Pharm Res; 2004 Aug; 21(8):1489-97. PubMed ID: 15359586
[TBL] [Abstract][Full Text] [Related]
4. P-glycoprotein efflux inhibition by amphiphilic diblock copolymers: relationship between copolymer concentration and substrate hydrophobicity.
Zastre JA; Jackson JK; Wong W; Burt HM
Mol Pharm; 2008; 5(4):643-53. PubMed ID: 18380467
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and micellar characterization of short block length methoxy poly(ethylene glycol)-block-poly(caprolactone) diblock copolymers.
Letchford K; Zastre J; Liggins R; Burt H
Colloids Surf B Biointerfaces; 2004 May; 35(2):81-91. PubMed ID: 15261040
[TBL] [Abstract][Full Text] [Related]
6. Solubilization of hydrophobic drugs by methoxy poly(ethylene glycol)-block-polycaprolactone diblock copolymer micelles: theoretical and experimental data and correlations.
Letchford K; Liggins R; Burt H
J Pharm Sci; 2008 Mar; 97(3):1179-90. PubMed ID: 17683080
[TBL] [Abstract][Full Text] [Related]
7. The combined use of paclitaxel-loaded nanoparticles with a low-molecular-weight copolymer inhibitor of P-glycoprotein to overcome drug resistance.
Wan CP; Letchford K; Jackson JK; Burt HM
Int J Nanomedicine; 2013; 8():379-91. PubMed ID: 23378760
[TBL] [Abstract][Full Text] [Related]
8. Reversal of multidrug resistance by methoxypolyethylene glycol-block-polycaprolactone diblock copolymers through the inhibition of P-glycoprotein function.
Elamanchili P; McEachern C; Burt H
J Pharm Sci; 2009 Mar; 98(3):945-58. PubMed ID: 18623213
[TBL] [Abstract][Full Text] [Related]
9. In vivo fate of unimers and micelles of a poly(ethylene glycol)-block-poly(caprolactone) copolymer in mice following intravenous administration.
Liu J; Zeng F; Allen C
Eur J Pharm Biopharm; 2007 Mar; 65(3):309-19. PubMed ID: 17257817
[TBL] [Abstract][Full Text] [Related]
10. In vitro human plasma distribution of nanoparticulate paclitaxel is dependent on the physicochemical properties of poly(ethylene glycol)-block-poly(caprolactone) nanoparticles.
Letchford K; Liggins R; Wasan KM; Burt H
Eur J Pharm Biopharm; 2009 Feb; 71(2):196-206. PubMed ID: 18762253
[TBL] [Abstract][Full Text] [Related]
11. Curcumin-encapsulated MePEG/PCL diblock copolymeric micelles: a novel controlled delivery vehicle for cancer therapy.
Mohanty C; Acharya S; Mohanty AK; Dilnawaz F; Sahoo SK
Nanomedicine (Lond); 2010 Apr; 5(3):433-49. PubMed ID: 20394536
[TBL] [Abstract][Full Text] [Related]
12. Indomethacin-loaded methoxy poly(ethylene glycol)/ poly(epsilon-caprolactone) diblock copolymeric nanosphere: pharmacokinetic characteristics of indomethacin in the normal Sprague-Dawley rats.
Kim SY; Lee YM; Shin HJ; Kang JS
Biomaterials; 2001 Jul; 22(14):2049-56. PubMed ID: 11426885
[TBL] [Abstract][Full Text] [Related]
13. Methoxy poly(ethylene glycol)-block-poly(delta-valerolactone) copolymer micelles for formulation of hydrophobic drugs.
Lee H; Zeng F; Dunne M; Allen C
Biomacromolecules; 2005; 6(6):3119-28. PubMed ID: 16283736
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of MePEG-PCL diblock copolymers: surface properties and controlled release behavior.
Mohanty AK; Jana U; Manna PK; Mohanta GP
Prog Biomater; 2015; 4(2-4):89-100. PubMed ID: 26566467
[TBL] [Abstract][Full Text] [Related]
15. Copolymer micelles and nanospheres with different in vitro stability demonstrate similar paclitaxel pharmacokinetics.
Letchford K; Burt HM
Mol Pharm; 2012 Feb; 9(2):248-60. PubMed ID: 22204437
[TBL] [Abstract][Full Text] [Related]
16. Polyether-polyester diblock copolymers for the preparation of paclitaxel loaded polymeric micelle formulations.
Liggins RT; Burt HM
Adv Drug Deliv Rev; 2002 Feb; 54(2):191-202. PubMed ID: 11897145
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and characterization of six-arm star poly(delta-valerolactone)-block-methoxy poly(ethylene glycol) copolymers.
Zeng F; Lee H; Chidiac M; Allen C
Biomacromolecules; 2005; 6(4):2140-9. PubMed ID: 16004456
[TBL] [Abstract][Full Text] [Related]
18. Fine tuning micellar core-forming block of poly(ethylene glycol)-block-poly(ε-caprolactone) amphiphilic copolymers based on chemical modification for the solubilization and delivery of doxorubicin.
Yan J; Ye Z; Chen M; Liu Z; Xiao Y; Zhang Y; Zhou Y; Tan W; Lang M
Biomacromolecules; 2011 Jul; 12(7):2562-72. PubMed ID: 21598958
[TBL] [Abstract][Full Text] [Related]
19. Methoxy poly(ethylene glycol)/epsilon-caprolactone amphiphilic block copolymeric micelle containing indomethacin. I. Preparation and characterization.
Shin IG; Kim SY; Lee YM; Cho CS; Sung YK
J Control Release; 1998 Jan; 51(1):1-11. PubMed ID: 9685899
[TBL] [Abstract][Full Text] [Related]
20. Hydrophilic block azidation of PCL-b-PEO block copolymers from epichlorohydrin.
Liu J; Gan Z
Macromol Biosci; 2014 May; 14(5):699-708. PubMed ID: 24469998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
